2013
DOI: 10.5897/ajppx12.015
|View full text |Cite
|
Sign up to set email alerts
|

Antimalarial drugs: Mode of action and status of resistance

Abstract: Malaria is a major global health problem, with an estimated 300 to 500 million clinical cases occurring annually. Malaria remains one of the leading causes of disease and death in the tropics, mainly of children under 5 years of age. The most prevalent and dangerous type of malaria is caused by Plasmodium falciparum. P. vivax is a common cause of malaria in Latin America, Asia, and Oceania, but not Africa. P. malariae and P. ovale are much less common. Antimalarials are used in three different ways: prophylaxi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
27
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(29 citation statements)
references
References 84 publications
2
27
0
Order By: Relevance
“…111 Though effective, antifolates may cause hematologic effects if administered for a prolonged period of time. These drugs function by interfering with folate metabolism thus disrupting the pathway critical for the survival of the malaria parasite.…”
Section: Antifolatessupporting
confidence: 93%
“…111 Though effective, antifolates may cause hematologic effects if administered for a prolonged period of time. These drugs function by interfering with folate metabolism thus disrupting the pathway critical for the survival of the malaria parasite.…”
Section: Antifolatessupporting
confidence: 93%
“…P. vivax is a common cause of malaria in Latin America, Asia, and Oceania, but not Africa. P. malariae and P. ovale are much less common (Saifi et al 2013). P. falciparum is responsible for the vast majority of deaths from malaria (Lothar et al 2008).…”
Section: Introductionmentioning
confidence: 99%
“…These drugs have been classified according to the stages at which they intervene in the parasite life cycle [37]. Schizonticide drugs used for causal prophylaxis, such as pyrimethamine and primaquine, act on the primary plasmodial tissue, which, after growth in the liver, develops into active erythrocytes [38]. These drugs can also act on the hypnozoites of P. vivax and P. ovale, which can produce a relapse of symptoms once reactivated [38].…”
Section: Mechanistic Insightmentioning
confidence: 99%